We recently met with IBSA, the sole manufacturer of the only licensed HCG product in the UK. While IBSA expects to distribute some HCG starting from the end of January, it has become clear that HCG will likely remain constrained in the short term, not meeting demand of all patients in the UK.
This means that, for the time being, we must prioritise supply of HCG based on clinical need. Because HCG plays a particularly important role in fertility, we are prioritising access to patients who are actively trying to conceive or plan to do so in the near future.
We are sending out emails to patients based on previous information we have for you on file regarding your desires around fertility and conceptions and based on that the next steps will be laid out. We are aware that the information we may hold for you may not be complete or the most up to date, so there is opportunity to adjust preferences where required.
Please follow the steps outlined in that email to ensure we can manage this process as smoothly as possible.
If you have not been informed you are clinically prioritised, but conceiving children is a priority for you, or you are unsure about your options, you can speak to a doctor about your treatment, fertility planning, or whether any changes are right for you. You can book in for a review call with a doctor here.
